Esperion Therapeutics, Inc. (ESPR) ownership: Top institutional holder: VANGUARD GROUP INC ($55.30M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 14945454.00 | $55.30M | 2025-12-31 |
| BlackRock, Inc. | 17852427.00 | $48.92M | 2026-03-31 |
| WASATCH ADVISORS LP | 15768897.00 | $43.21M | 2026-03-31 |
| Two Seas Capital LP | 11394833.00 | $31.22M | 2026-03-31 |
| ORBIMED ADVISORS LLC | 10570300.00 | $28.96M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 10433760.00 | $28.59M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 9458779.00 | $25.92M | 2026-03-31 |
| MARSHALL WACE, LLP | 7075083.00 | $19.39M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-05-28 | |
| Sell | null | 2026-05-28 | |
| Sell | null | 2026-05-28 | |
| Sell | null | 2026-05-28 | |
| Sell | null | 2026-05-28 |
Back to ESPR overview · ESPR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.